PubMed · 3223297
Cistiside-M, a new protective agent.
Abstract
The toxicological and radiopharmacological properties of the agent Cistiside-M (2-mercaptoethylamine adenosine-5-phosphate) were investigated on male mice, lines C57Bl and H. The compound was administered intraperitoneally in doses from 1000 to 125 mg/kg, 15 min prior to lethal gamma-irradiation using a 137Cs source in the 6 to 15 Gy range. The radioprotective effect was assessed by the integral indices of 30-day survival, mean survival time, coefficient of protection alpha, S30 and the dose-reduction factor (DRF). The compound was characterized by low toxicity and good antiradiation effect in a wide dose range. Maximum degree of radioprotection (75% survival) was established when the agent was administered in a dose of 1000 mg/kg. DRF was 1.6. The dose of 250 mg/kg was interesting--with 50% survival rate and increase of the therapeutic index to 5.6. The low toxicity and the considerable radioprotective effect of the compound are due to its complex structure.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Minkova, T Pantev, R Georgieva. 1988. Cistiside-M, a new protective agent.. https://pubmed.ncbi.nlm.nih.gov/3223297/
Cite the original work for its findings. Save a collection to share your selection of sources.